Dr Reddy's Srikakulam unit classified as voluntary action indicated by USFDA

Dr Reddy's Laboratories has received a report from the US Food and Drug Administration. The report concerns its manufacturing facility in Srikakulam, Andhra Pradesh. The USFDA has classified the inspection outcome as Voluntary Action Indicated. This means the inspection is officially closed. The company received the Establishment Inspection Report on October 20, 2025.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BPErcRQ
via IFTTT